Companies in #Immune and Inflammatory Diseases

Triveni Bio is a private clinical-stage biotechnology company developing novel antibody therapeutics for immune and inflammatory diseases using a genetics-informed precision medicine approach. The company raised $65M in June 2026 ahead of upcoming readouts on its lead eczema drug programs, advancing first-in-class functional antibodies for I&I disorders with defined genetic patient stratification strategies.